Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin <i>via</i> the PI3K/AKT Signaling Pathway.

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway.

Wu, Li-Mei; Liao, Xiao-Zhong; Zhang, Yan; He, Zi-Rui; Nie, Shi-Qing; Ke, Bin; Shi, Lin; Zhao, Jian-Fu; Chen, Wen-Hui.

Afiliação

Wu LM; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Liao XZ; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhang Y; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
He ZR; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Nie SQ; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Ke B; Department of Traditional Chinese Medicine, Cancer Center of Sun Yat-sen University, Guangzhou, China.
Shi L; Department of Traditional Chinese Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhao JF; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Chen WH; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.